{"id":4462,"count":2,"description":"Hyperthyroidism (overactive thyroid) most commonly caused by Graves' disease (autoimmune TSH-receptor antibody-mediated), toxic multinodular goitre, or solitary toxic adenoma. Symptoms include weight loss with normal\/increased appetite, palpitations, tremor, heat intolerance, anxiety, frequent stools, and (in Graves') eye signs (proptosis, lid lag, ophthalmopathy). The MedsBase Overactive Thyroid Treatment catalogue carries the antithyroid thionamide drugs that block thyroid peroxidase and reduce hormone synthesis.\n\n<strong>Op\u021biuni disponibile.<\/strong> Metimazolul (tionamida modern\u0103 preferat\u0103 \u2014 dozare o dat\u0103 pe zi, mai pu\u021bin hepatotoxic dec\u00e2t propiltiouracilul, cu excep\u021bia primului trimestru de sarcin\u0103 \u0219i a crizei tiroidee) este disponibil sub form\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/methimez\/\">Methimez<\/a>. Carbimazolul (prodrogul metimazolului, utilizat pe scar\u0103 larg\u0103 \u00een Marea Britanie\/Europa\/India\/Asia) sub form\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/neomercazole\/\">Neomercazole<\/a>.\n\n<strong>Insomnia acut\u0103 pe termen scurt (jet lag, doliu, stres tranzitoriu) \u2014 melatonina 1\u20133 mg cu 30\u201360 de minute \u00eenainte de culcare timp de 1\u20132 s\u0103pt\u0103m\u00e2ni. Tulburarea de faz\u0103 de somn \u00eent\u00e2rziat\u0103 (\u00een special la adolescen\u021bi \u0219i lucr\u0103torii \u00een schimburi) \u2014 melatonina 0,5\u20131 mg luat\u0103 cu 4\u20136 ore \u00eenainte de momentul dorit de adormire. Insomnia cronic\u0103 (mai mult de 3 luni) \u2014 terapia cognitiv-comportamental\u0103 pentru insomnie (CBT-I) este de prim\u0103 inten\u021bie; op\u021biuni farmacologice pentru cazuri selectate sub supraveghere medical\u0103.<\/strong> Initial dose for moderate Graves' disease: methimazole 15\u201330 mg daily or carbimazole 20\u201340 mg daily, titrated based on TSH and free T4 measured every 4\u20136 weeks. Most patients achieve euthyroid state within 6\u201312 weeks. Long-term options: continue antithyroid drug for 12\u201318 months (40% remission rate after stopping in Graves'), radioactive iodine ablation (definitive but causes permanent hypothyroidism), or surgical thyroidectomy. Beta-blockers (propranolol \u2014 see <a href=\"https:\/\/medsbase.com\/ro\/heart-blood-pressure\/\">S\u0103n\u0103tate cardiac\u0103 \u0219i tensiune arterial\u0103<\/a>) pentru controlul simptomatic al palpita\u021biilor, tremorului \u0219i anxiet\u0103\u021bii \u00een timp ce se a\u0219teapt\u0103 efectul medicamentului antitiroidian.\n\n<strong>Important.<\/strong> <strong>Analizele de baz\u0103 obligatorii \u00eenainte de tratament: hemogram\u0103 complet\u0103 \u0219i teste de func\u021bie hepatic\u0103.<\/strong> Medicamentele antitiroidiene provoac\u0103 agranulocitoz\u0103 la 0,1\u20130,5% dintre pacien\u021bi (de obicei \u00een primele 90 de zile, risc mai mare la doze mari) \u2014 febr\u0103 brusc\u0103, durere \u00een g\u00e2t, ulcera\u021bii bucale necesit\u0103 hemogram\u0103 imediat\u0103 \u0219i \u00eentreruperea tratamentului dac\u0103 exist\u0103 neutropenie. Hepatotoxicitate \u2014 propiltiouracilul mai mult dec\u00e2t metimazolul; monitorizarea func\u021biei hepatice \u00een primele faze ale tratamentului. Sarcina: propiltiouracilul este preferat \u00een primul trimestru (mai pu\u021bin teratogen \u2014 aplasia cutis \u0219i atrezie coanal\u0103 induse de metimazol), apoi trecerea la metimazol \u00een al doilea trimestru. Tiroidita subacut\u0103 se manifest\u0103 cu hipertiroidism, dar NU r\u0103spunde la medicamentele antitiroidiene (AINS \u0219i beta-blocante sunt potrivite; scanarea tiroidei ajut\u0103 la diferen\u021biere). Toate produsele MedsBase sunt expediate din <strong>produc\u0103tori certifica\u021bi WHO-GMP<\/strong> \u0219i sunt acoperite de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>.","link":"https:\/\/medsbase.com\/ro\/overactive-thyroid-treatment\/","name":"Tratament pentru hipertiroidism","slug":"overactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/4462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product?product_cat=4462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}